NCT03773562View on ClinicalTrials.gov

Imaging the Migraine Brain Pre- and Post-Erenumab

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Migraine

Interventions

DRUG

Erenumab

Erenumab will be used per label instructions.

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER